Cantel Medical (Cantel Medical) Cash-to-Debt : 0.23 (As of Apr. 2021)

View and export this data going back to 1992. Start your Free Trial

What is Cantel Medical Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Cantel Medical's cash to debt ratio for the quarter that ended in Apr. 2021 was 0.23.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Cantel Medical couldn't pay off its debt using the cash in hand for the quarter that ended in Apr. 2021.

The historical rank and industry rank for Cantel Medical's Cash-to-Debt or its related term are showing as below:

CMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04 Med: 0.28 Max: No Debt
Current: 0.23

During the past 13 years, Cantel Medical's highest Cash to Debt Ratio was No Debt. The lowest was 0.04. And the median was 0.28.

CMD's Cash-to-Debt is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.87 vs CMD: 0.23

Cantel Medical Cash-to-Debt Historical Data

The historical data trend for Cantel Medical's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Cantel Medical Cash-to-Debt Chart

Cantel Medical Annual Data

Trend

Jul11

Jul12

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Cash-to-Debt

Get a 7-Day Free Trial

0.25

0.29

0.48

0.19

0.25

Cantel Medical Quarterly Data
	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21
Cash-to-Debt	Get a 7-Day Free Trial															0.11	0.25	0.25	0.25	0.23

Competitive Comparison of Cantel Medical's Cash-to-Debt

For the Medical Instruments & Supplies subindustry, Cantel Medical's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantel Medical's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cantel Medical's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Cantel Medical's Cash-to-Debt falls into.

Cantel Medical Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Cantel Medical's Cash to Debt Ratio for the fiscal year that ended in Jul. 2020 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	277.871	/	(17.643	+	1092.348)
	=	0.25

Cantel Medical's Cash to Debt Ratio for the quarter that ended in Apr. 2021 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	218.528	/	(40.082	+	903.318)
	=	0.23

Cantel Medical (NYSE:CMD) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Cantel Medical Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Cantel Medical's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantel Medical (Cantel Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cantel Medical Corp (NYSE:CMD) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 Clove Road, 9th Floor, Little Falls, NJ, USA, 07424

Website

http://www.cantelmedical.com

Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.

Executives

Ann E Berman	director	255 STATE STREET, BOSTON MA 02109
Jeffrey Z Mann	officer: SVP, General Counsel	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
George L Fotiades	director, officer: Chief Executive Officer	281 SUMMIT AVENUE, SUMMIT NJ 07901
Charles M Diker	director, 10 percent owner, officer: Chairman	ONE NEW YORK PLAZA, NEW YORK NY 10004
Shaun M. Blakeman	officer: SVP - CFO	C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Jean Casner	officer: SVP and CHRO	150 CLOVE ROAD, LITTLE FALLS NJ 07424
Brian Capone	officer: SVP and Princ. Accounting Ofr	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Peter G Clifford	officer: President and COO	40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047
Seth M Yellin	officer: Executive Vice President	150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424
Laura L Forese	director	849 STONEWALL COURT FRANKLIN LAKES NJ 07417
Peter Pronovost	director	JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231
Anthony B Evnin	director	C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Ronnie Myers	director	TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595
Alan R Batkin	director	399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022
Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316